Skip to main content
. 2022 Mar 31;41(4):462–472. doi: 10.23876/j.krcp.21.284

Table 3.

Within- and between-group interaction effects on frailty, dialysis adequacy, and quality of life (n = 39)

Variable Time (wk) Exercise group (n = 18) Control group (n = 21) F p-value Repeated measures of ANCOVA
F p-value η₂ (f)
Frailty (score)a Baseline 2.22 ± 1.22 2.52 ± 0.87 0.35 0.56 Time 1.80 0.17d 0.048
4th 1.33 ± 1.14c 2.95 ± 1.02 17.52 <0.001 Group 18.55 <0.001 0.340
8th 1.11 ± 0.90c 3.05 ± 1.02 26.47 <0.001 T*G 21.74 <0.001d 0.376 (0.78)
12th 0.94 ± 0.93c 3.10 ± 1.04 34.71 <0.001
Gait speed (m/sec) Baseline 0.89 ± 0.22 0.83 ± 0.24 0.21 0.65 Time 8.18 0.003d 0.185
4th 1.14 ± 0.30c 0.76 ± 0.22 11.88 0.001 Group 12.64 0.001 0.260
8th 1.18 ± 0.31c 0.72 ± 0.19 20.23 <0.001 T*G 32.2 <0.001d 0.464 (0.93)
12th 1.21 ± 0.31c 0.71 ± 0.19 24.26 <0.001
Grip strength (kg) Baseline 23.58 ± 9.79 26.10 ± 8.83 1.27 0.27 Time 1.92 0.15d 0.051
4th 24.00 ± 9.16 21.13 ± 9.51 0.18 0.68 Group 0.05 0.83 0.001
8th 25.28 ± 8.45 22.40 ± 9.78 0.52 0.48 T*G 9.73 <0.001d 0.213 (0.52)
12th 25.61 ± 8.88 22.07 ± 8.41 0.75 0.39
Exhaustion (vitality in SF-36, score) Baseline 48.46 ± 12.80 46.24 ± 10.79 1.27 0.27 Time 1.17 0.33 0.031
4th 53.16 ± 12.06 44.11 ± 9.78 7.60 0.009 Group 9.96 0.003 0.217
8th 53.66 ± 8.99 41.68 ± 8.34 15.08 <0.001 T*G 2.27 0.09 0.059 (0.25)
12th 53.82 ± 10.06 43.26 ± 6.80 12.38 0.001
Weight loss (BMI, kg/m2) Baseline 21.55 ± 2.31 21.68 ± 3.06 0.03 0.88 Time 3.35 0.05d 0.085
4th 21.53 ± 2.16 21.68 ± 3.02 0.03 0.86 Group 0.03 0.88 0.001
8th 21.53 ± 2.01 21.64 ± 2.77 0.04 0.84 T*G 1.67 0.20d 0.044 (0.21)
12th 21.58 ± 1.98 21.79 ± 3.01 0.24 0.63
SPPB (score)b Baseline 10.67 ± 1.61 10.10 ± 2.02 0.07 0.79 Time 4.31 0.03d 0.009
4th 11.56 ± 0.98c 9.52 ± 2.06 8.73 0.005 Group 8.73 0.006 0.142
8th 11.72 ± 0.67c 9.86 ± 2.20 6.96 0.01 T*G 28.81 <0.001d 0.168 (0.45)
12th 11.83 ± 0.51c 9.76 ± 2.28 9.89 0.003
Kt/V urea Baseline 1.64 ± 0.19 1.67 ± 0.19 0.14 0.71 Time 0.46 0.67d 0.013
4th 1.68 ± 0.24 1.71 ± 0.24 0.05 0.82 Group 0.29 0.59 0.008
8th 1.70 ± 0.23 1.71 ± 0.28 0.14 0.71 T*G 2.85 0.05d 0.073 (0.28)
12th 1.76 ± 0.30 1.64 ± 0.18 2.40 0.13
Physical component summary Baseline 45.51 ± 6.48 44.50 ± 8.76 1.30 0.26 Time 5.59 0.003d 0.134
4th 49.41 ± 4.94 43.81 ± 7.38 8.35 0.007 Group 8.52 0.006 0.191
8th 50.31 ± 4.50 44.76 ± 6.88 7.41 0.01 T*G 1.98 0.13d 0.052 (0.23)
12th 51.80 ± 4.51 42.79 ± 8.38 10.95 0.002
Mental component summary Baseline 50.35 ± 11.04 49.81 ± 9.17 0.12 0.73 Time 0.90 0.97 0.003
4th 53.98 ± 7.83c 45.22 ± 8.64 9.41 0.004 Group 5.11 0.03 0.124
8th 53.24 ± 7.28c 44.95 ± 8.65 7.66 0.009 T*G 3.04 0.03 0.078 (0.29)
12th 53.23 ± 8.60 48.95 ± 8.14 2.92 0.10

Data are expressed as mean ± standard deviation.

BMI, body mass index; Kt/V, K = dialyzer’s capacity to clear urea at the blood flow rate, t = treatment time, V = distribution volume of urea; SF-36, Short Form-36 tool; SPPB, short physical performance battery; T*G, time*group.

F is effect size calculated using the analysis of covariance (ANCOVA) model adjusted for dialysis vintage in G*Power (small = 0.10, medium = 0.25, large = 0.40); F-score calculated using ANCOVA adjusted by dialysis vintage (exercise group vs. control group).

Score range:

a

0–5,

b

0–12.

c

Statistically significant based on Bonferroni correction (p < 0.013);

d

Greenhouse-Geisser correction according to Mauchly’s sphericity test (p < 0.05).